Maximum phonation time and air usage during phonation. Clinical study.

Minoru Hirano,Y. Koike,H. Leden

DOI: https://doi.org/10.1159/000263198

Abstract:

What problem does this paper attempt to address?

Trisomy 18 and Congenital Heart Disease: Single-Center Review of Outcomes and Parental Perspectives

Neena A. Davisson,Joseph B. Clark,Thomas K. Chin,Robert D. Tunks

DOI: https://doi.org/10.1177/2150135118782145

2018-08-29

World Journal for Pediatric and Congenital Heart Surgery

Abstract:Background: In patients with trisomy 18, congenital heart surgery is controversial due to anticipated poor patient outcome. Data are lacking regarding clinical outcomes and family opinions about care received. Methods: A retrospective chart review of patients with trisomy 18 and congenital heart disease from 2005 to 2017 was performed. Patients were grouped into those receiving cardiac intervention (surgery or cardiac catheterization) versus medical management. A telephone survey was used to assess completeness of family counseling provided prior to treatment selection and parental opinions on the care received. Results: Seventeen infants were assessed. In the medical management group (n = 7), there were five deaths at a median age of 1.5 months (range: 1.2-4.1 months) and two survivors aged 29 and 44 months at latest follow-up. In the intervention group (n = 10), cardiac surgery was performed in nine patients at a median age of 4.3 months (0.2-23.4 months) and weight of 3.2 kg (1.5-12.2 kg); catheter intervention was performed in one patient at one week of age. At latest follow-up, seven intervention patients are alive at a median age of 50 months (5-91 months). Survey respondents (n = 12) unanimously stated that their child’s quality of life was improved by their specific treatment strategy, that the experience of the parents was enhanced, and that they would choose the same treatment course again. Conclusions: Surgical repair may be associated with favorable early outcomes and may be judiciously offered in selected circumstances. In this limited experience, parental perceptions were positive regarding the quality of care and overall experience independent of the chosen treatment strategy or eventual outcome.
Non-mosaic trisomy 22 and congenital heart surgery using the shared decision making model: a case report

Vivien Phung,Kathryn E Singh,Saar Danon,Christopher A Tan,Sarah Dabagh

DOI: https://doi.org/10.1186/s12887-023-03949-8

2023-03-18

Abstract:Background: Liveborn infants with non-mosaic trisomy 22 are rarely described in the medical literature. Reported lifespan of these patients ranges from minutes to 3 years, with the absence of cardiac anomalies associated with longer-term survival. The landscape for offering cardiac surgery to patients with rare autosomal trisomies is currently evolving, as has been demonstrated recently in trisomies 13 and 18. However, limited available data on patients with rare autosomal trisomies provides a significant challenge in perinatal counseling, especially when there are options for surgical intervention. Case presentation: In this case report, we describe an infant born at term with prenatally diagnosed apparently non-mosaic trisomy 22 and multiple cardiac anomalies, including a double outlet right ventricle, hypoplastic aortic valve and severe aortic arch hypoplasia, who underwent cardiac surgery. The decisions made by her family lending to her progress and survival to this day were made with a focus on the shared decision making model and support in the prenatal and perinatal period. We also review the published data on survival and quality of life after cardiac surgery in infants with rare trisomies. Conclusions: This patient is the only known case of apparently non-mosaic trisomy 22 in the literature who has undergone cardiac surgery with significant survival benefit. This case highlights the impact of using a shared decision making model when there is prognostic uncertainty.
The American Association for Thoracic Surgery 2023 Expert Consensus Document: Recommendation for the care of children with trisomy 13 or trisomy 18 and a congenital heart defect

James D. St Louis,Aarti Bhat,John C. Carey,Angela E. Lin,Paul C. Mann,Laura Miller Smith,Benjamin S. Wilfond,Katherine V. Kosiv,Robert A. Sorabella,Bahaaldin Alsoufi

DOI: https://doi.org/10.1016/j.jtcvs.2023.11.054

IF: 6.439

2024-01-29

Journal of Thoracic and Cardiovascular Surgery

Abstract:Objectives Recommendations for surgical repair of a congenital heart defect in children with trisomy 13 or trisomy 18 remain controversial, are subject to biases, and are largely unsupported with limited empirical data. This has created significant distrust and uncertainty among parents and could potentially lead to suboptimal care for patients. A working group, representing several clinical specialties involved with the care of these children, developed recommendations to assist in the decision-making process for congenital heart defect care in this population. The goal of these recommendations is to provide families and their health care teams with a framework for clinical decision making based on the literature and expert opinions. Methods This project was performed under the auspices of the AATS Congenital Heart Surgery Evidence-Based Medicine Taskforce. A Patient/Population, Intervention, Comparison/Control, Outcome process was used to generate preliminary statements and recommendations to address various aspects related to cardiac surgery in children with trisomy 13 or trisomy 18. Delphi methodology was then used iteratively to generate consensus among the group using a structured communication process. Results Nine recommendations were developed from a set of initial statements that arose from the Patient/Population, Intervention, Comparison/Control, Outcome process methodology following the groups' review of more than 500 articles. These recommendations were adjudicated by this group of experts using a modified Delphi process in a reproducible fashion and make up the current publication. The Class (strength) of recommendations was usually Class IIa (moderate benefit), and the overall level (quality) of evidence was level C-limited data. Conclusions This is the first set of recommendations collated by an expert multidisciplinary group to address specific issues around indications for surgical intervention in children with trisomy 13 or trisomy 18 with congenital heart defect. Based on our analysis of recent data, we recommend that decisions should not be based solely on the presence of trisomy but, instead, should be made on a case-by-case basis, considering both the severity of the baby's heart disease as well as the presence of other anomalies. These recommendations offer a framework to assist parents and clinicians in surgical decision making for children who have trisomy 13 or trisomy 18 with congenital heart defect.

surgery,cardiac & cardiovascular systems,respiratory system
Contemporary Trends in Cardiac Surgical Care for Trisomy 13 and 18 Patients Admitted to Hospitals in the United States

Jason W. Greenberg,Kevin Kulshrestha,Aadhyasri Ramineni,David S. Winlaw,David G. Lehenbauer,Farhan Zafar,David S. Cooper,David L.S. Morales

DOI: https://doi.org/10.1016/j.jpeds.2024.113955

IF: 6.314

2024-02-09

The Journal of Pediatrics

Abstract:Objective To assess rates of cardiac surgery and the clinical and demographic features that influence surgical vs. non-surgical treatment of congenital heart disease (CHD) in patients with trisomy 13 (T13) and trisomy 18 (T18) in the United States. Study design A retrospective study was performed using the Pediatric Health Information System. All hospital admissions of children (<18 years of age) with T13 and T18 in the United States were identified from 2003 through 2022. ICD codes were used to identify presence of CHD, extracardiac comorbidities/malformations, and performance of cardiac surgery. Results 7,113 patients were identified. CHD was present in 62% (1,625/ 2,610) of patients with T13 and 73% (3,288/4,503) of patients with T18. The most common CHD morphologies were isolated atrial/ventricular septal defects (T13 40%, T18 42%) and aortic hypoplasia/coarctation (T13 21%, T18 23%). Single-ventricle morphologies comprised 6% (100/1,625) of the T13 and 5% (167/3,288) of the T18 CHD cohorts. Surgery was performed in 12% of patients with T13 plus CHD and 17% of patients with T18 plus CHD. For all cardiac diagnoses, <50% of patients received surgery. Non-surgical patients were more likely to be born prematurely (p<0.05 for T13 and T18). The number of extracardiac comorbidities was similar between surgical/non-surgical patients with T13 (median 2 vs. 2, p=0.215) and greater in surgical vs. non-surgical patients with T18 (median 3 vs. 2, p<0.001). Hospital mortality was <10% for both surgical cohorts. Conclusions Patients with T13 or T18 and CHD receive surgical palliation, but at a low prevalence ( < 17%) nationally. Given operative mortality <10%, opportunity exists perhaps for quality improvement in the performance of cardiac surgery for these vulnerable patient populations.

pediatrics
Operative and nonoperative outcomes in patients with trisomy 13 and 18 with congenital heart disease

Christina L Greene,Antonia Schulz,Mariana Chávez,Steven J Staffa,David Zurakowski,Kevin G Friedman,Sitaram M Emani,Christopher W Baird

DOI: https://doi.org/10.1016/j.xjon.2024.06.007

2024-06-22

JTCVS Open

Abstract:Objective: To evaluate the short- and long-term outcomes of cardiac repair versus nonoperative management in patients with trisomy 13 and trisomy 18 with congenital heart disease. Methods: An institutional review board-approved, retrospective review was undertaken to identify all patients admitted with trisomy 13/18 and congenital heart disease. Patients were divided into 2 cohorts (operated vs nonoperated) and compared. Results: Between 1985 and 2023, 62 patients (34 operated and 28 nonoperated) with trisomy 13 (n = 9) and trisomy 18 (n = 53) were identified. The operated cohort was 74% girls, underwent mainly The Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery mortality category 1 procedures (n = 24 [71%]) at a median age of 2.5 months (interquartile range [IQR], 1.3-4.5 months). This compares with the nonoperative cohort where 64% (n = 18) would have undergone The Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery mortality category 1 procedures if surgery would have been elected. The most common diagnosis was ventricular septal defect. Postoperative median intensive care unit stay was 6.5 days (IQR, 3.7-15 days) with a total hospital length of stay of 15 days (IQR, 11-49 days). Thirty-day postoperative survival was 94%. There were 5 in-hospital deaths in the operated and 7 in the nonoperated cohort. Median follow-up was 15.4 months (IQR, 4.3-48.7 months) for the operated and 11.2 months (IQR, 1.2-48.3 months) for the nonoperated cohorts. One-year survival was 79% operated versus 51.5% nonoperated (P < .003). Nonoperative treatment had an increased risk of mortality (hazard ratio, 3.28; 95% CI, 1.46-7.4; P = .004). Conclusions: Controversy exists regarding the role of primary cardiac repair in patients with trisomy 13/18 and congenital heart disease. Cardiac repair can be performed safely with low early mortality and operated patients had higher long-term survival compared with nonoperated in our cohort.
Building trust and improving communication with parents of children with Trisomy 13 and 18: A mixed-methods study

Annie Janvier,Barbara Farlow,Keith J Barrington,Claude Julie Bourque,Tracy Brazg,Benjamin Wilfond

DOI: https://doi.org/10.1177/0269216319860662

Abstract:Background: Trisomy 13 and trisomy 18 are common life-limiting conditions associated with major disabilities. Many parents have described conflictual relationships with clinicians, but positive and adverse experiences of families with healthcare providers have not been well described. Aim: (1) To investigate parental experiences with clinicians and (2) to provide practical recommendations and behaviors clinicians could emulate to avoid conflict. Design: Participants were asked to describe their best and worse experiences, as well as supportive clinicians they met. The results were analyzed using mixed methods. Setting/participants: Parents of children with trisomy 13 and 18 who were part of online social support networks. A total of 503 invitations were sent, and 332 parents completed the questionnaire about 272 children. Results: The majority of parents (72%) had met a supportive clinician. When describing clinicians who changed their lives, the overarching theme, present in 88% of answers, was trust. Parents trusted clinicians when they felt he or she cared and valued their child, their family, and made them feel like good parents (69%), had appropriate knowledge (66%), and supported them and gave them realistic hope (42%). Many (42%) parents did not want to make-or be part of-life-and-death decisions. Parents gave specific examples of supportive behaviors that can be adopted by clinicians. Parents also described adverse experiences, generally leading to conflicts and lack of trust. Conclusion: Realistic and compassionate support of parents living with children with trisomy 13 and 18 is possible. Adversarial interactions that lead to distrust and conflicts can be avoided. Many supportive behaviors that inspire trust can be emulated.
[The effect of biomaterials and other industrial materials on the growth of several aerobic bacterial species in vitro].

H. Oehring,E. Beleites,E. Straube,U. Völker,R. Müller

1992-02-01

Abstract:The article deals with interactions between bio-vitro-materials and bacteria species in vitro. The growth of S. aureus, Sc. salivarius, E. coli and Ps. aeruginosa in a salt solution with and without addition of biomaterials was examined until the day 60 in a static culture. By counting the cfu/ml and determination the relative change of germ capacity the results were compared. The data of such series obtained with working materials of similar chemical composition were collected and evaluated. We found, that Ps. aeruginosa was promoted in growth by all materials, especially those, which contained carbon. The same can be said about the last materials and E. coli. In contrast as well Ca- and P-containing as--free biomaterials reduced the numbers of germs. Changes of multiplying of S. aureus and Sc. salivarius seldom were observed. It ist apparent, that the biomaterials tested are not indifferent against a few germs, which may cause infections, but they promote the growth of a few species in vitro. This may favour an infection, if such materials should be implanted. It is proposed to test biomaterials microbiologically before clinical application. Materials with indifferent behavior or low anti-microbiological effect have to be favoured.
Studies on reproduction in rats with meclofenamate sodium, a nonsteroidal anti-inflammatory agent.

J. Petrere,R. R. Humphrey,J. Anderson,J. E. Fitzgerald,F. A. de la Iglesia

DOI: https://doi.org/10.1016/0272-0590(85)90190-3

1985-08-01

Fundamental and Applied Toxicology

Abstract:
"She was finally mine": the moral experience of families in the context of trisomy 13 and 18- a scoping review with thematic analysis

Zoe Ritchie,Gail Teachman,Randi Zlotnik Shaul,Maxwell J Smith

DOI: https://doi.org/10.1186/s12910-023-00994-x

2024-03-02

Abstract:Introduction: The value of a short life characterized by disability has been hotly debated in the literature on fetal and neonatal outcomes. Methods: We conducted a scoping review to summarize the available empirical literature on the experiences of families in the context of trisomy 13 and 18 (T13/18) with subsequent thematic analysis of the 17 included articles. Findings: Themes constructed include (1) Pride as Resistance, (2) Negotiating Normalcy and (3) The Significance of Time. Interpretation: Our thematic analysis was guided by the moral experience framework conceived by Hunt and Carnevale (2011) in association with the VOICE (Views On Interdisciplinary Childhood Ethics) collaborative research group. Relevance: This article will be of interest and value to healthcare professionals and bioethicists who support families navigating the medically and ethically complex landscape of T13/18.
Family‐Centered Antenatal Care With a Life‐Limiting Fetal Condition: A Developmental Theory‐Guided Approach

Carrie J. Henry,Denise Côté‐Arsenault

DOI: https://doi.org/10.1111/jmwh.13710

2024-11-28

Abstract:Trisomy 18 (T18) is the second‐most common autosomal trisomy and includes multiple anomalies, growth restriction, and a severely shortened life span, often lasting only hours or days. Côté‐Arsenault and Denney‐Koelsch extended Reva Rubin's work, describing the psychosocial stages of pregnancy by describing the stages and developmental tasks for a pregnancy altered by a life‐limiting fetal condition such as T18. When a diagnosis of T18 is made prenatally, the pregnancy changes dramatically, although it remains a psychosocial developmental process. The extended stages of pregnancy with T18 or another life‐limiting fetal condition are: Pre‐Diagnosis, Learning the Diagnosis, Living With the Diagnosis, Birth and Death, and Post Death. As they navigate these stages, parents must also address 7 developmental tasks of pregnancy, which are (1) Navigating Relationships, (2) Comprehending Implications of the Condition, (3) Revising Goals of Pregnancy, (4) Making the Most of Time With Baby, (5) Preparing for Birth and Inevitable Death, (6) Advocating for Baby With Integrity, and (7) Adjusting to Life in Absence of Baby. Knowledgeable health care providers can do much more than support parents through grief and facilitate discussions about birth planning. This case report highlights the importance of a knowledgeable provider who can help parents navigate the stages and tasks of pregnancy, empowering them to make choices consistent with their values so they have no regrets.

nursing
Perspectives of Challenges in Counseling for Congenital Heart Defects

Joyce L. Woo,Rupali Gandhi,Shelvonne Burton,Adithya Sivakumar,Sarah Spiewak,Renee Wakulski,William A. Grobman,Matthew M. Davis,Angira Patel,Joyce T. Johnson,Stefani Samples,Lynn M. Yee

DOI: https://doi.org/10.1007/s00246-024-03520-x

2024-06-23

Pediatric Cardiology

Abstract:Prior work regarding counseling patients about congenital heart defects (CHD) has focused on their perceptions about accurate communication of cardiac anatomy, and the emotional support received from the provider. The objectives of this study were to identify the additional CHD counseling-specific challenges and areas for future intervention, using a practical communication framework. This is a secondary analysis of qualitative data provided by caretakers of infants who received congenital heart surgery from 2019 to 2020 in the Chicagoland area. While the survey in the primary study pertained to barriers in obtaining prenatal diagnosis, respondents with both prenatal and postnatal diagnosis reported challenges to effective counseling. Qualitative data measuring counseling challenges were collected from semi-structured phone interviews. Thematic analysis was performed using an inductive approach. Themes were organized into five domains using SPIKES (Setting, Perception, Invitation, Knowledge, Empathy, and Summarize/Strategy), a previously validated framework to help clinicians effectively break bad news. Among 160 survey respondents, 35 (21.9%) reported a challenge during CHD counseling that they received. In total, 12 challenges were identified and spanned all six SPIKES domains. The three most common challenges were as follows: perception of repeated imaging studies for accurate diagnosis or management ( n = 19, Knowledge), the lack of cardiologist presence at the time of initial CHD detection ( n = 8, Setting), and insufficient information provided about the CHD diagnosis ( n = 7, Knowledge). Patients perceive counseling as a key component of prenatal diagnosis of CHD and identify the challenges that exist at all stages of the counseling process. These findings suggest that effective counseling extends beyond conveying information about anatomy and prognosis.

pediatrics,cardiac & cardiovascular systems
Trisomy 13, home health-care and multidisciplinary approach: Case report

Patrícia Zschaber Anacleto,Virginia Araújo de Sousa,Julliane V Joviano-Santos

DOI: https://doi.org/10.1590/1984-0462/2025/43/2024018

2024-10-04

Abstract:Objective: To recognize and address Patau's syndrome, despite its rarity and associated low life expectancy, through the presentation of a case study of a 2-year-old patient receiving Home Care services. Case description: We present a female patient who defied the odds with a prolonged survival, possible due to Home Care. She was delivered via cesarean section at 31 weeks + 4 days due to restricted uterine growth. The mother, aged 36, had received proper prenatal care and was in good health. The diagnosis of Patau's syndrome was confirmed through karyotyping after birth. Despite the severe clinical nature of the case, the patient, now with two years old, receives specialized home-based care, supported by a tracheostomy and gastrostomy. A dedicated 24-hour nursing technician ensures continuous monitoring, and the patient benefits from regular medical check-ups, physiotherapy five times a week, weekly speech therapy sessions, monthly consultations with a nutritionist, and ongoing psychological support for her family members. Comments: This multidisciplinary approach has resulted in a slight motor response, highlighting the positive impact of comprehensive care on her overall well-being. The existence of a robust support network for families facing similar challenges is crucial, and a multidisciplinary care can effectively prevent complications associated with this impactful syndrome.
Transforming congenital heart disease management: Advances in fetal cardiac interventions

Stephanie Guseh,Wayne Tworetzky

DOI: https://doi.org/10.1002/pd.6592

2024-05-22

Prenatal Diagnosis

Abstract:This review addresses the transformative advancements in fetal cardiac interventions (FCI) for congenital heart diseases (CHD), with a particular focus on aortic stenosis with evolving hypoplastic left heart syndrome, pulmonary atresia with an intact ventricular septum, and HLHS with an intact atrial septum (HLHS‐IAS). We outline the specific FCI techniques employed, the refined criteria for selecting appropriate fetal and maternal candidates, and the promising yet varied outcomes associated with these procedures. Procedural strategies and clinical decision‐making are examined as we take into account the fetal pathophysiology and the benefits and risks of early intervention. We highlight the role of multidisciplinary teams in improving technical success and managing immediate procedural complications, which have led to significant improvements in procedural outcomes. Additionally, the review discusses the long‐term outcomes, challenges, and future research directions in FCI, emphasizing the necessity for continuous innovation and collaboration across specialties to advance the management of CHD. The integration of new technologies and research findings holds the promise of further enhancing FCI success rates and patient outcomes.

genetics & heredity,obstetrics & gynecology
Evaluating How Beliefs Among Pediatric Cardiology Providers May Affect Fetal Cardiac Counseling—A National Perspective

Caitlin S. Haxel,Christina Ronai,Anna M. Martens,Chelsey C. Lim,Nelangi Pinto,Joanne S. Chiu

DOI: https://doi.org/10.1002/pd.6706

2024-12-01

Prenatal Diagnosis

Abstract:Background Prenatal counseling following a fetal diagnosis of critical congenital heart disease (CCHD) is challenging and requires delivery of detailed and complete information to ensure appropriate decision making and pregnancy support. Methods An anonymous 50‐item survey was distributed to providers who performed fetal cardiac counseling. The primary purpose was to evaluate on a national scale physician beliefs and attitudes toward available choices after a fetal diagnosis of CCHD and their association with reported counseling practices. Participants were specifically asked to indicate how likely they were to recommend postnatal interventional and/or surgical treatment, postnatal palliative care, or termination of pregnancy. The primary outcome variables were provider responses to statements about pregnancies complicated by CCHD diagnosed in utero. Results There were 138 respondents, with most somewhat or strongly agreeing that providing counseling on surgical and catheter‐based interventions anticipated in the short‐ and long‐term (99%, 136/138), counseling on a "comfort care" alternative with limited intervention (97%, 134/138), and options for pregnancy termination at different stages (91%, 126/138) should be included. Physicians that disagreed with the statement "some life is better than no life at all" were statistically more likely (p

genetics & heredity,obstetrics & gynecology
Birth in the Operating Room for Immediate Cardiac Surgery: A Rare but Effective Strategy

Spencer J Hogue,Amir Mehdizadeh-Shrifi,Kevin Kulshrestha,James F Cnota,Allison Divanovic,Marco Ricci,Awais Ashfaq,David G Lehenbauer,David S Cooper,David L S Morales

DOI: https://doi.org/10.1177/21501351241269881

Abstract:Background: With significant advancements in fetal cardiac imaging, patients with complex congenital heart disease (CHD) carrying a high risk for postnatal demise are now being diagnosed earlier. We sought to assess an interdisciplinary strategy for delivering these children in an operating room (OR) adjacent to a cardiac OR for immediate surgery or stabilization. Methods: All children prenatally diagnosed with CHD at risk for immediate postnatal hemodynamic instability and cardiogenic shock who were delivered in the operating room (OR) between 2012 and 2023 in which the senior author was consulted were included. Results: Eight patients were identified. Six (75%) patients were operated on day-of-life zero, all requiring obstructed total anomalous pulmonary venous return (TAPVR) repair. Of these six patients, 2 (33%) required a simultaneous Norwood procedure, 2 (33%) required pulmonary artery unifocalization and modified Blalock-Taussig-Thomas shunt, and 2 (33%) patients had repair of obstructed mixed TAPVR. The remaining 2 patients potentially planned for immediate surgery had nonimmune hydrops fetalis and went into cardiogenic shock at 12 and 72 hours postnatally, requiring a novel Norwood procedure with left-ventricular exclusion for severe aortic/mitral valve insufficiency. The median ventilation and inpatient durations were 19 [IQR: 11-26] days and 41 [IQR: 32-128] days, respectively. Three(38%) patients required one or more in-hospital reoperations. Subsequent staged procedures included Glenn (n = 5), Fontan (n = 3), biventricular repair (n = 2), ventricular assist device placement (n = 1), and heart transplant (n = 1). Median follow-up was 5.7 [IQR:1.3-7.8] years. The five-year postoperative survival was 88% (n = 7/8). Conclusion: While children with these diagnoses have historically had poor survival, the strategy of birth in the OR adjacent to a cardiac OR where emergent surgery is planned is a potentially promising strategy with excellent clinical outcomes. However, this is a high-resource strategy whose feasibility in any program requires thoughtful assessment.
Fetal therapies - (Stem cell transplantation; enzyme replacement therapy; in utero genetic therapies)

Rachel Sagar,Anna L David

DOI: https://doi.org/10.1016/j.bpobgyn.2024.102542

2024-09-11

Abstract:Advances in ultrasound and prenatal diagnosis are leading an expansion in the options for parents whose fetus is identified with a congenital disease. Obstetric diseases such as pre-eclampsia and fetal growth restriction may also be amenable to intervention to improve maternal and neonatal outcomes. Advanced Medicinal Therapeutic Products such as stem cell, gene, enzyme and protein therapies are most commonly being investigated as the trajectory of treatment for severe genetic diseases moves toward earlier intervention. Theoretical benefits include prevention of in utero damage, smaller treatment doses compared to postnatal intervention, use of fetal circulatory shunts and induction of immune tolerance. New systematic terminology can capture adverse maternal and fetal adverse events to improve safe trial conduct. First-in-human clinical trials are now beginning to generate results with a focus on safety first and efficacy second. If successful, these trials will transform the care of fetuses with severe early-onset congenital disease.
Spontaneously Corrected Hypoplastic Left Heart: A Case Report and Exceptional Opportunity to Discuss Etiology with Novel Therapeutic Vision

Mohsen Shahidi

DOI: https://doi.org/10.34172/aim.31185

2024-09-01

Abstract:Hypoplastic left heart syndrome (HLHS) is a relatively prevalent fetal echocardiography finding in complex congenital heart diseases. Current studies indicate that intrinsic and extrinsic mechanisms could be involved in the development of left heart hypoplasia. Left ventricular inflow or outflow disorders may cause left heart hypoplasia. Prenatal aortic valvuloplasty has become more common as a therapeutic strategy. Our case presentation provides an opportunity for a new vision toward the etiology, prevention, and treatment of HLHS. In our patient, prenatal progressive left heart hypoplasia associated with restrictive foramen oval (FO) suggested the likelihood of a flow-mediated mechanism. Additionally, postnatal improvement of the hypoplastic left heart in the presence of a functional perimembranous ventricular septal defect (PM-VSD) reinforced the suspicion of an extrinsic mechanism. Pre- or postnatal interventional creation of an atrial septal defect (ASD) or VSD is our proposed method for HLHS in selected patients.
[The value of sequential CD 34 measurement for carrying out stem cell pheresis].

P. Kier,K. Huber,R. Ruckser,K. Habertheuer,K. Bauer,P. Höcker,M. Kurz,E. Tiefengraber,C. Sebesta,W. Hinterberger

Wiener klinische Wochenschrift

Abstract:The recent significant improvement in disease-free survival in patients with certain haematological malignancies is due to high-dose chemotherapy and subsequent autologous bone marrow and/or stem cell transplantation. The proliferation and egression of stem cells into the peripheral blood must first be stimulated by defined chemotherapy and/or by administration of cytokines. However, the increase of circulating stem cells in peripheral blood is limited to only a few days. By immunologically analysing white blood cells for the expression of the surface antigen CD 34 it is possible to calculate the numbers of haematopoietic progenitor cells. Thus, besides monitoring haematopoietic recovery, the estimation of CD34+ cells in the peripheral blood can be used to indicate the optimal time point for stem cell collection. Two to four stem cell pheresis (one per day) may then yield sufficient stem cells to enable the safe and rapid reconstitution of haematopoiesis following supralethal chemotherapy.
Fetal Echocardiographic Evaluation of Tricuspid Valve and Right Ventricular Function Including Global Longitudinal Strain in Hypoplastic Left Heart Syndrome and Association with Postnatal Outcomes

Benjamin Ittleman,Sarah Lowenstein,Lindsay A. Edwards,Elizabeth Caris,Aarti Bhat,Jeffrey Conwell,Mark Lewin,Bhawna Arya

DOI: https://doi.org/10.1007/s00246-024-03453-5

2024-04-24

Pediatric Cardiology

Abstract:Despite significant advancements in the care of patients with hypoplastic left heart syndrome (HLHS) morbidity and mortality remain high. Postnatal right ventricular dysfunction and tricuspid regurgitation (TR) are associated with worse outcomes in HLHS. We aim to determine if right ventricle functional parameters and TR on fetal echocardiogram are associated with postnatal outcomes in HLHS patients. Retrospective review was performed on all fetuses with HLHS from 2014 to 2022 at our institution. Initial and follow up fetal echocardiogram measurements of right ventricular myocardial performance index (MPI), fractional area change (FAC) and global longitudinal strain (GLS) were retrospectively measured. The presence and severity of TR was recorded from the fetal echocardiogram reports. Postnatal outcomes including transplant-free survival, hospital length of stay > 30 days after initial palliation and need for bidirectional Glenn at < 4 months were reviewed. Forty-three subjects met inclusion criteria. Mean gestational age at presentation was 26.1 ± 5.9 weeks. Nine subjects died and 3 required heart transplantation. Initial fetal echocardiogram MPI was significantly lower (better) (0.36 ± 0.06 vs 0.44 ± 0.11; p = < 0.001) and FAC was significantly higher (better) (45 ± 6% vs 40 ± 8%; p = 0.035) in transplant-free survivors. Fetal right ventricular GLS and presence of mild TR were not associated with postnatal outcome. In fetuses with HLHS, abnormal MPI and right ventricular FAC are associated with decreased transplant-free survival. There was no observed association between GLS and postnatal outcomes. To our knowledge this is the first study examining fetal right ventricular function and GLS in HLHS patients and its link to postnatal outcomes.

pediatrics,cardiac & cardiovascular systems
Swine dysentery.

D. L. Harris,R. Glock

Journal of the American Veterinary Medical Association

Abstract:

Maximum phonation time and air usage during phonation. Clinical study.

Trisomy 18 and Congenital Heart Disease: Single-Center Review of Outcomes and Parental Perspectives

Non-mosaic trisomy 22 and congenital heart surgery using the shared decision making model: a case report

The American Association for Thoracic Surgery 2023 Expert Consensus Document: Recommendation for the care of children with trisomy 13 or trisomy 18 and a congenital heart defect

Contemporary Trends in Cardiac Surgical Care for Trisomy 13 and 18 Patients Admitted to Hospitals in the United States

Operative and nonoperative outcomes in patients with trisomy 13 and 18 with congenital heart disease

Building trust and improving communication with parents of children with Trisomy 13 and 18: A mixed-methods study

[The effect of biomaterials and other industrial materials on the growth of several aerobic bacterial species in vitro].

Studies on reproduction in rats with meclofenamate sodium, a nonsteroidal anti-inflammatory agent.

"She was finally mine": the moral experience of families in the context of trisomy 13 and 18- a scoping review with thematic analysis

Family‐Centered Antenatal Care With a Life‐Limiting Fetal Condition: A Developmental Theory‐Guided Approach

Perspectives of Challenges in Counseling for Congenital Heart Defects

Trisomy 13, home health-care and multidisciplinary approach: Case report

Transforming congenital heart disease management: Advances in fetal cardiac interventions

Evaluating How Beliefs Among Pediatric Cardiology Providers May Affect Fetal Cardiac Counseling—A National Perspective

Birth in the Operating Room for Immediate Cardiac Surgery: A Rare but Effective Strategy

Fetal therapies - (Stem cell transplantation; enzyme replacement therapy; in utero genetic therapies)

Spontaneously Corrected Hypoplastic Left Heart: A Case Report and Exceptional Opportunity to Discuss Etiology with Novel Therapeutic Vision

[The value of sequential CD 34 measurement for carrying out stem cell pheresis].

Fetal Echocardiographic Evaluation of Tricuspid Valve and Right Ventricular Function Including Global Longitudinal Strain in Hypoplastic Left Heart Syndrome and Association with Postnatal Outcomes

Swine dysentery.